Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPIC: Ivermectin in Early COVID-19
NCT04405843Phase 3Completed
- Sponsor
- Centro de Estudios en Infectología Pediátrica
- Start
- Jul 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of CHILD-IVITAB in coronavirus disease 2019 (COVID-19), sponsored by Centro de Estudios en Infectología Pediátrica. Started Jul 2020; status: completed.
02
Drugs
CHILD-IVITAB
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04405843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04405843.